- Wednesday, September 12th 2018 at 15:00 - 16:00 UK (Other timezones)
- General participation info | Participate online | + Phone in United States (Toll Free): 1 877 309 2073 United States: +1 (571) 317-3129 Australia (Toll Free): 1 800 193 385 Australia: +61 2 8355 1020 Austria (Toll Free): 0 800 202148 Belgium (Toll Free): 0 800 78884 Canada (Toll Free): 1 888 455 1389 Denmark (Toll Free): 8090 1924 France (Toll Free): 0 805 541 047 Germany (Toll Free): 0 800 184 4222 Greece (Toll Free): 00 800 4414 3838 Hungary (Toll Free): (06) 80 986 255 Iceland (Toll Free): 800 9869 Ireland (Toll Free): 1 800 946 538 Israel (Toll Free): 1 809 454 830 Italy (Toll Free): 800 793887 Japan (Toll Free): 0 120 663 800 Luxembourg (Toll Free): 800 22104 Netherlands (Toll Free): 0 800 020 0182 New Zealand (Toll Free): 0 800 47 0011 Norway (Toll Free): 800 69 046 Poland (Toll Free): 00 800 1213979 Portugal (Toll Free): 800 819 575 Spain (Toll Free): 800 900 582 Sweden (Toll Free): 0 200 330 905 Switzerland (Toll Free): 0 800 740 393 United Kingdom (Toll Free): 0 800 169 0432 Access Code: 731-636-357
The notion of competition between “model-free” and “model-based” reinforcement learning systems has become an important theme in the study of decision making, with numerous applications to psychiatry. I discuss new data suggesting that competition is arbitrated by a cost-benefit metacontrol algorithm, weighing the benefits of model-based accuracy against the cognitive costs of its execution. In a large sample from the general population, many measures of psychopathology show deficits in model-based control, but importantly these deficits can be ameliorated by manipulating the incentives.
Sam Gershman
Assistant Professor
Department of Psychology and Center for Brain Science
Harvard University
Sam Gershman – Metacontrol of reinforcement learning across the psychopathology spectrum